Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Schmertzler currently holds 155,266 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Schmertzler has been a net buyer of PTCT stock. They have purchased $13.9M and sold $3.2M worth of shares.
Michael Schmertzler's most recent insider trade was on Dec 16, 2025, when they sold 24,000 shares at $30.86 per share.
Michael Schmertzler serves as Executive at PTC THERAPEUTICS, INC. (PTCT). They have executed 40 insider transactions totaling $17.1M over their tenure at the company.
Michael Schmertzler holds the position of Executive at PTC THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Michael Schmertzler has shown a buying trading pattern, with $13.9M in total purchases and $3.2M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael Schmertzler was on Jun 25, 2013, when they purchased $8.0M worth of PTCT shares. This transaction involved 533,333 shares at $15.00 per share.
Michael Schmertzler currently owns 155,266 shares of PTC THERAPEUTICS, INC. (PTCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Schmertzler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Schmertzler has 40 Form 4 filings on record as an insider at PTC THERAPEUTICS, INC..
Set alerts for Michael Schmertzler and 40,000+ other insiders.